US Stock MarketDetailed Quotes

SNSE Sensei Biotherapeutics

Watchlist

0.669
0.0000.00%

Close Jul 22 16:00 ET

16.78MMarket Cap-552P/E (TTM)

Sensei Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

35.11%-7.62M

17.94%-32.02M

35.63%-6.16M

31.49%-4.66M

20.47%-9.46M

-9.17%-11.74M

-28.97%-39.03M

-21.68%-9.57M

-21.98%-6.8M

-96.78%-11.9M

Net income from continuing operations

21.47%-7.99M

29.82%-34.1M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-32.05%-48.59M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

Operating gains losses

----

1,106.67%302K

--0

140.00%6K

--200K

740.00%96K

94.97%-30K

--0

97.35%-15K

--0

Depreciation and amortization

-7.54%331K

0.30%1.35M

-6.27%329K

-2.92%332K

3.75%332K

7.19%358K

96.64%1.35M

6.69%351K

151.47%342K

162.30%320K

Other non cash items

17.09%370K

13.65%1.36M

20.52%370K

6.00%318K

19.26%353K

8.59%316K

1,994.74%1.19M

501.96%307K

29,900.00%300K

14,700.00%296K

Change In working capital

55.32%-1.43M

-529.56%-4.33M

-161.07%-400K

-78.46%979K

51.35%-1.72M

-378.86%-3.19M

761.54%1.01M

604.30%655K

75.62%4.55M

-309.70%-3.53M

-Change in prepaid assets

54.68%-716K

82.99%-99K

-26.42%337K

-75.05%473K

172.23%671K

21.28%-1.58M

-170.29%-582K

-29.75%458K

-1.04%1.9M

-468.65%-929K

-Change in payables and accrued expense

26.45%306K

-215.57%-2.33M

-324.46%-781K

-78.92%471K

15.47%-2.26M

-90.85%242K

241.44%2.02M

81.93%-184K

201.89%2.23M

-465.71%-2.68M

-Change in other current assets

800.00%56K

340.00%22K

73.08%-7K

2.33%-42K

178.22%79K

-104.57%-8K

101.53%5K

69.41%-26K

86.89%-43K

-380.56%-101K

-Change in other current liabilities

-36.53%-370K

-11.48%-1.27M

-24.91%-366K

-5.24%-301K

-21.01%-334K

5.24%-271K

-656.59%-1.14M

-172.17%-293K

-10.42%-286K

-4,700.00%-276K

-Change in other working capital

55.42%-703K

-191.68%-650K

-40.43%417K

-49.19%378K

-71.18%132K

-32.19%-1.58M

-15.29%709K

407.25%700K

43.35%744K

-30.08%458K

Cash from discontinued investing activities

Operating cash flow

35.11%-7.62M

17.94%-32.02M

35.63%-6.16M

31.49%-4.66M

20.47%-9.46M

-9.17%-11.74M

-28.97%-39.03M

-21.68%-9.57M

-21.98%-6.8M

-96.78%-11.9M

Investing cash flow

Cash flow from continuing investing activities

149.57%5.77M

-23.10%38.41M

-48.50%8.26M

-2.41%8.31M

47.97%19.53M

-81.04%2.31M

134.90%49.95M

185.87%16.04M

1,867.01%8.52M

108.93%13.2M

Net PPE purchase and sale

73.94%-37K

95.42%-14K

--0

346.15%128K

-647.37%-142K

82.08%-306K

--0

-235.71%-235K

91.56%-52K

Net investment purchase and sale

136.63%5.81M

-23.54%38.43M

-48.50%8.26M

-5.03%8.31M

46.42%19.4M

-79.91%2.45M

135.54%50.26M

160.99%16.04M

2,224.27%8.75M

109.00%13.25M

Cash from discontinued investing activities

Investing cash flow

149.57%5.77M

-23.10%38.41M

-48.50%8.26M

-2.41%8.31M

47.97%19.53M

-81.04%2.31M

134.90%49.95M

185.87%16.04M

1,867.01%8.52M

108.93%13.2M

Financing cash flow

Cash flow from continuing financing activities

20.23%-209K

-3,793.03%-11.17M

-247.58%-431K

-1,454.60%-2.53M

-6,577.31%-7.95M

-320.17%-262K

-100.18%-287K

-5.08%-124K

-2,228.57%-163K

-981.82%-119K

Net issuance payments of debt

-6.99%-199K

-20.99%-761K

-10.73%-196K

-16.56%-190K

-21.15%-189K

-39.85%-186K

-146.67%-629K

22.03%-177K

-2,228.57%-163K

-1,318.18%-156K

Net common stock issuance

----

---10.38M

---252K

---2.34M

----

--0

----

Proceeds from stock option exercised by employees

----

-85.96%48K

-67.92%17K

--0

----

213.76%342K

-50.93%53K

--0

--37K

Net other financing activities

86.84%-10K

---76K

--0

---76K

----

Cash from discontinued financing activities

Financing cash flow

20.23%-209K

-3,793.03%-11.17M

-247.58%-431K

-1,454.60%-2.53M

-6,577.31%-7.95M

-320.17%-262K

-100.18%-287K

-5.08%-124K

-2,228.57%-163K

-981.82%-119K

Net cash flow

Beginning cash position

-26.88%13.01M

148.57%17.8M

-0.93%11.34M

3.30%10.23M

-7.02%8.11M

148.57%17.8M

-56.86%7.16M

20.11%11.45M

-36.54%9.9M

-94.85%8.72M

Current changes in cash

78.78%-2.06M

-144.98%-4.78M

-73.71%1.67M

-27.98%1.12M

79.71%2.12M

-720.10%-9.69M

212.71%10.64M

367.27%6.35M

125.57%1.55M

100.77%1.18M

End cash Position

35.11%10.96M

-26.88%13.01M

-0.93%11.34M

3.30%10.23M

-7.02%8.11M

148.57%17.8M

20.11%11.45M

-36.54%9.9M

Free cash flow

35.62%-7.65M

18.16%-32.2M

35.63%-6.16M

33.91%-4.66M

20.58%-9.49M

-10.38%-11.89M

-21.87%-39.35M

-13.94%-9.57M

-18.24%-7.05M

-79.36%-11.95M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	35.11%-7.62M	17.94%-32.02M	35.63%-6.16M	31.49%-4.66M	20.47%-9.46M	-9.17%-11.74M	-28.97%-39.03M	-21.68%-9.57M	-21.98%-6.8M	-96.78%-11.9M
Net income from continuing operations	21.47%-7.99M	29.82%-34.1M	39.39%-7.41M	46.90%-7.12M	10.91%-9.39M	17.96%-10.18M	-32.05%-48.59M	-30.60%-12.23M	-38.52%-13.42M	-7.82%-10.54M
Operating gains losses	----	1,106.67%302K	--0	140.00%6K	--200K	740.00%96K	94.97%-30K	--0	97.35%-15K	--0
Depreciation and amortization	-7.54%331K	0.30%1.35M	-6.27%329K	-2.92%332K	3.75%332K	7.19%358K	96.64%1.35M	6.69%351K	151.47%342K	162.30%320K
Other non cash items	17.09%370K	13.65%1.36M	20.52%370K	6.00%318K	19.26%353K	8.59%316K	1,994.74%1.19M	501.96%307K	29,900.00%300K	14,700.00%296K
Change In working capital	55.32%-1.43M	-529.56%-4.33M	-161.07%-400K	-78.46%979K	51.35%-1.72M	-378.86%-3.19M	761.54%1.01M	604.30%655K	75.62%4.55M	-309.70%-3.53M
-Change in prepaid assets	54.68%-716K	82.99%-99K	-26.42%337K	-75.05%473K	172.23%671K	21.28%-1.58M	-170.29%-582K	-29.75%458K	-1.04%1.9M	-468.65%-929K
-Change in payables and accrued expense	26.45%306K	-215.57%-2.33M	-324.46%-781K	-78.92%471K	15.47%-2.26M	-90.85%242K	241.44%2.02M	81.93%-184K	201.89%2.23M	-465.71%-2.68M
-Change in other current assets	800.00%56K	340.00%22K	73.08%-7K	2.33%-42K	178.22%79K	-104.57%-8K	101.53%5K	69.41%-26K	86.89%-43K	-380.56%-101K
-Change in other current liabilities	-36.53%-370K	-11.48%-1.27M	-24.91%-366K	-5.24%-301K	-21.01%-334K	5.24%-271K	-656.59%-1.14M	-172.17%-293K	-10.42%-286K	-4,700.00%-276K
-Change in other working capital	55.42%-703K	-191.68%-650K	-40.43%417K	-49.19%378K	-71.18%132K	-32.19%-1.58M	-15.29%709K	407.25%700K	43.35%744K	-30.08%458K
Cash from discontinued investing activities
Operating cash flow	35.11%-7.62M	17.94%-32.02M	35.63%-6.16M	31.49%-4.66M	20.47%-9.46M	-9.17%-11.74M	-28.97%-39.03M	-21.68%-9.57M	-21.98%-6.8M	-96.78%-11.9M
Investing cash flow
Cash flow from continuing investing activities	149.57%5.77M	-23.10%38.41M	-48.50%8.26M	-2.41%8.31M	47.97%19.53M	-81.04%2.31M	134.90%49.95M	185.87%16.04M	1,867.01%8.52M	108.93%13.2M
Net PPE purchase and sale	73.94%-37K	95.42%-14K	--0	--0	346.15%128K	-647.37%-142K	82.08%-306K	--0	-235.71%-235K	91.56%-52K
Net investment purchase and sale	136.63%5.81M	-23.54%38.43M	-48.50%8.26M	-5.03%8.31M	46.42%19.4M	-79.91%2.45M	135.54%50.26M	160.99%16.04M	2,224.27%8.75M	109.00%13.25M
Cash from discontinued investing activities
Investing cash flow	149.57%5.77M	-23.10%38.41M	-48.50%8.26M	-2.41%8.31M	47.97%19.53M	-81.04%2.31M	134.90%49.95M	185.87%16.04M	1,867.01%8.52M	108.93%13.2M
Financing cash flow
Cash flow from continuing financing activities	20.23%-209K	-3,793.03%-11.17M	-247.58%-431K	-1,454.60%-2.53M	-6,577.31%-7.95M	-320.17%-262K	-100.18%-287K	-5.08%-124K	-2,228.57%-163K	-981.82%-119K
Net issuance payments of debt	-6.99%-199K	-20.99%-761K	-10.73%-196K	-16.56%-190K	-21.15%-189K	-39.85%-186K	-146.67%-629K	22.03%-177K	-2,228.57%-163K	-1,318.18%-156K
Net common stock issuance	----	---10.38M	---252K	---2.34M	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	----	-85.96%48K	-67.92%17K	--0	----	----	213.76%342K	-50.93%53K	--0	--37K
Net other financing activities	86.84%-10K	---76K	--0	--0	--0	---76K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	20.23%-209K	-3,793.03%-11.17M	-247.58%-431K	-1,454.60%-2.53M	-6,577.31%-7.95M	-320.17%-262K	-100.18%-287K	-5.08%-124K	-2,228.57%-163K	-981.82%-119K
Net cash flow
Beginning cash position	-26.88%13.01M	148.57%17.8M	-0.93%11.34M	3.30%10.23M	-7.02%8.11M	148.57%17.8M	-56.86%7.16M	20.11%11.45M	-36.54%9.9M	-94.85%8.72M
Current changes in cash	78.78%-2.06M	-144.98%-4.78M	-73.71%1.67M	-27.98%1.12M	79.71%2.12M	-720.10%-9.69M	212.71%10.64M	367.27%6.35M	125.57%1.55M	100.77%1.18M
End cash Position	35.11%10.96M	-26.88%13.01M	-26.88%13.01M	-0.93%11.34M	3.30%10.23M	-7.02%8.11M	148.57%17.8M	148.57%17.8M	20.11%11.45M	-36.54%9.9M
Free cash flow	35.62%-7.65M	18.16%-32.2M	35.63%-6.16M	33.91%-4.66M	20.58%-9.49M	-10.38%-11.89M	-21.87%-39.35M	-13.94%-9.57M	-18.24%-7.05M	-79.36%-11.95M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall